Exploring biomarkers and molecular mechanisms of Type 2 diabetes mellitus promotes colorectal cancer progression based on transcriptomics
Abstract Type 2 diabetes mellitus (T2DM) has been confirmed as an independent risk factor for colorectal cancer (CRC) in many studies. However, the mechanisms behind T2DM’s role in the progression of CRC remain unclear. This study aims to explore the potential biomarkers and molecular mechanisms inv...
Saved in:
Main Authors: | Simin Luo, Yuhong Zhu, Zhanli Guo, Chuan Zheng, Xi Fu, Fengming You, Xueke Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88520-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
by: O. I. Kit, et al.
Published: (2014-12-01) -
The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review
by: Faris Shweikeh, et al.
Published: (2024-01-01) -
Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
by: N. B. Zakharzhevskaya, et al.
Published: (2015-12-01) -
Features of development and progression of colorectal cancer on a background of ulcerative colitis
by: I. L. Khalif, et al.
Published: (2012-02-01) -
Collagen turnover biomarkers to predict outcome of patients with biliary cancer
by: Leonard Kaps, et al.
Published: (2025-02-01)